Dr. Lal PathLabs Limited (LALPATHLAB.NS)
INR 3018.6
(-0.67%)
INR 3018.6
(-0.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.13 Billion INR | -54.81% |
| 2022 | 9.48 Billion INR | 11.98% |
| 2021 | 8.46 Billion INR | 36.61% |
| 2020 | 6.19 Billion INR | 6.51% |
| 2019 | 5.81 Billion INR | 10.08% |
| 2018 | 5.28 Billion INR | 12.88% |
| 2017 | 4.68 Billion INR | -7.44% |
| 2016 | 5.05 Billion INR | 15.99% |
| 2015 | 4.36 Billion INR | 11.35% |
| 2014 | 3.91 Billion INR | 19.94% |
| 2013 | 3.26 Billion INR | 18.34% |
| 2012 | 2.75 Billion INR | 39.28% |
| 2011 | 1.98 Billion INR | 49.87% |
| 2010 | 1.32 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.72 Billion INR | 0.45% |
| 2024 Q1 | 1.12 Billion INR | 1.26% |
| 2023 Q1 | 2.42 Billion INR | 1.68% |
| 2023 FY | 4.28 Billion INR | -54.81% |
| 2023 Q3 | 2.49 Billion INR | -0.87% |
| 2023 Q4 | 1.1 Billion INR | -55.61% |
| 2023 Q2 | 2.51 Billion INR | 3.92% |
| 2022 Q3 | 2.34 Billion INR | -1.76% |
| 2022 Q1 | 2.37 Billion INR | 3.8% |
| 2022 FY | 9.48 Billion INR | 11.98% |
| 2022 Q4 | 2.38 Billion INR | 1.79% |
| 2022 Q2 | 2.38 Billion INR | 0.42% |
| 2021 Q2 | 1.83 Billion INR | -8.27% |
| 2021 FY | 8.46 Billion INR | 36.61% |
| 2021 Q3 | 2.35 Billion INR | 28.45% |
| 2021 Q1 | 1.99 Billion INR | 19.81% |
| 2021 Q4 | 2.28 Billion INR | -2.8% |
| 2020 Q2 | 1.59 Billion INR | 22.55% |
| 2020 Q4 | 1.66 Billion INR | 2.27% |
| 2020 FY | 6.19 Billion INR | 6.51% |
| 2020 Q1 | 1.3 Billion INR | -11.29% |
| 2020 Q3 | 1.62 Billion INR | 1.94% |
| 2019 FY | 5.81 Billion INR | 10.08% |
| 2019 Q4 | 1.46 Billion INR | -0.61% |
| 2019 Q3 | 1.47 Billion INR | 1.79% |
| 2019 Q2 | 1.45 Billion INR | 2.61% |
| 2019 Q1 | 1.41 Billion INR | 3.48% |
| 2018 Q4 | 1.36 Billion INR | 2.28% |
| 2018 Q3 | 1.33 Billion INR | 0.98% |
| 2018 Q2 | 1.32 Billion INR | 5.66% |
| 2018 Q1 | 1.25 Billion INR | 1.95% |
| 2018 FY | 5.28 Billion INR | 12.88% |
| 2017 Q2 | 1.14 Billion INR | 5.22% |
| 2017 Q4 | 1.23 Billion INR | -1.84% |
| 2017 FY | 4.68 Billion INR | -7.44% |
| 2017 Q3 | 1.25 Billion INR | 9.05% |
| 2017 Q1 | 1.09 Billion INR | 1.05% |
| 2016 Q4 | 1.08 Billion INR | 4.66% |
| 2016 FY | 5.05 Billion INR | 15.99% |
| 2016 Q3 | 1.03 Billion INR | -1.22% |
| 2016 Q2 | 1.04 Billion INR | 5.69% |
| 2016 Q1 | 989.1 Million INR | 12.5% |
| 2015 Q4 | 879.2 Million INR | 32.09% |
| 2015 FY | 4.36 Billion INR | 11.35% |
| 2015 Q1 | 899 Million INR | -35.6% |
| 2015 Q2 | 1.18 Billion INR | 31.38% |
| 2015 Q3 | 665.6 Million INR | -43.65% |
| 2014 Q3 | 782.4 Million INR | 0.0% |
| 2014 FY | 3.91 Billion INR | 19.94% |
| 2014 Q4 | 1.39 Billion INR | 78.43% |
| 2013 FY | 3.26 Billion INR | 18.34% |
| 2012 FY | 2.75 Billion INR | 39.28% |
| 2011 FY | 1.98 Billion INR | 49.87% |
| 2010 FY | 1.32 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 1.33 Billion INR | -209.839% |
| Metropolis Healthcare Limited | 3.3 Billion INR | -25.274% |
| Thyrocare Technologies Limited | 1.59 Billion INR | -158.634% |
| Vijaya Diagnostic Centre Limited | 985.79 Million INR | -319.489% |
| Vimta Labs Limited | 1.05 Billion INR | -291.034% |